Dermira (DERM) Tops Q3 EPS by 11c

Dermira (NASDAQ: DERM) reported Q3 EPS of ($0.23), $0.11 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $18.99 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• AMC Entertainment prices $200M stock offering to redeem senior notes